One year of rHuEPO therapy prolongs RBC survival and may stabilize RBC membranes despite natural progression of chronic renal failure to uremia and need for dialysis.
Year: 1990
Type: article
Source: PubMed
Authors: A B Schwartz, B Kelch, L Terzian, J Prior, K E Kim, E Pequinot, S B Kahn
Institution: Hahnemann University Hospital
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W176811959